Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 9,518

Document Document Title
WO/2019/195278A1
Compounds, conjugates and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed compounds may be useful, among other things, in treating of cancer and inhibiting ALK5. Compou...  
WO/2019/192532A1
Provided herein are are porphyrinato-lanthanide complexes useful as theranostic agents and methods of preparation and use thereof. The porphyrinato-lanthanide complexes are useful in the treatment and imaging of cancer.  
WO/2019/191539A1
Embodiments are directed to catalyst systems comprising: a procatalyst; and a co-catalyst, the co-catalyst comprising: a non-coordinating borate anion having the formula [B(C6F5)4]1- and a cation according to formula (I).  
WO/2019/186497A1
The disclosure relates to pharmaceutical compositions, to methods of preparing such compositions, and to methods for using such compositions for treating or preventing a disease or condition associated with arginase activity.  
WO/2019/189037A1
Provided is a fused-ring compound which exhibits excellent charge transport capacity. This fused-ring compound is represented by formula (1) having a specific structure.  
WO/2019/182993A1
The present disclosure is directed to a silicon-terminated telechelic polyolefin composition comprising a compound of formula (I). Embodiments related to a process for preparing the silicon-terminated telechelic polyolefin composition co...  
WO/2019/182986A1
A process to functionalized organo-metal compounds with silyl-based electrophiles. The process includes combining an organo-metal compound, a silyl-based functionalization agent, and an optional solvent. Functionalized silanes and silyl-...  
WO/2019/182983A1
The present disclosure is directed to a silicon-terminated organo-metal composition comprising a compound of formula (I). Embodiments relate to a process for preparing the silicon-terminated organo-metal composition comprising the compou...  
WO/2019/179798A1
The present application discloses a lanthanide chelate of formula (I) or a salt thereof, wherein at least one of Ch1 and Ch2 is an amide that forms a coordinate bond with the lanthanide. The application also discloses a detection agent c...  
WO/2019/181017A1
Provided is a novel boron isotope (10B) tracing drug for use in neutron beam dynamic therapy (NBDT) and boron neutron capture therapy (BNCT). The novel boron isotope (10B) tracking-type drug represented by chemical formula 3 exhibits loc...  
WO/2018/074231A9
The present invention relates to: a method for producing a particulate aluminum alloy and a composition containing said aluminum alloy that comprises a step for pulverizing an aluminum alloy in a hydrocarbon solvent in the presence of an...  
WO/2019/175149A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.  
WO/2019/177873A1
Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as arginase inhibitors and can be useful in preventing, treating or acting as a remedial agent for arginase-related...  
WO/2019/175828A1
The present invention is directed to a new fluoro-pyridinone hydroxamic acid phosphates and boronates of Formulae (I), (II) and (III) wherein Q is selected from the group consisting of –P(O)(OH)2, –P(O)(OH)(O-M+), –P(O)(O-M+)2 and ...  
WO/2019/178305A1
The present invention is directed to new pyridinone or pyrimidinone hydroxamic acid phosphates of Formula (1 ) and boronates of Formula (2), stereoisomers thereof; wherein Q is selected from the group consisting of -P(0)(OH)2, -P(0)(OH)(...  
WO/2019/173814A1
The present invention relates in part protective groups that can be used to reversibly protect benzoxaboroles and/or oxaboroles and yield the corresponding protected complexes. The invention further relates to the use of these protective...  
WO/2019/173188A1
Compounds that are inhibitors of at least one of the ARG1 and ARG2, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment ...  
WO/2019/169815A1
A radioactive molecular probe and an application thereof in detection of intravital islets, its structure is: formula (I), wherein R 1 are halogen, saturated aliphatic hydrocarbon group, unsaturated aliphatic hydrocarbon group and aromat...  
WO/2019/172150A1
Provided is a 2,3-bisphosphinopyrazine derivative represented by general formula (1). (In the formula: R1, R2, R3 and R4 represent an optionally-substituted linear or branched alkyl group having 1–10 carbon atoms, an optionally-substit...  
WO/2018/144607A8
A process for a continuous production of a boronic acid derivative and an apparatus of performing the process are disclosed.  
WO/2019/163738A1
The present invention relates to a method of production of 4-boronophenylalanine (BPA) from 4-iodophenylalanine, in which all the functional groups of the amino acid are protected by benzyl protection method, and which uses isopropyl mag...  
WO/2019/164340A1
The present specification relates to a heterocyclic compound represented by chemical formula 1, and an organic light-emitting device comprising same.  
WO/2019/162391A1
The invention relates to a novel method for producing fluorinated heterocyclic aliphatic compounds from the analogous aromatic compounds by hydrogenating with an Rh-catalyst system.  
WO/2019/164331A1
The present specification relates to a heterocyclic compound represented by chemical formula 1, and an organic light-emitting device comprising same.  
WO/2019/159120A1
Disclosed are compounds of formula (Ia) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (Ia) and methods of using the same for treating cancer or a respiratory inflammatory disea...  
WO/2019/155911A1
Provided are: a color conversion composition containing at least one compound represented by a specific general formula; a compound which is represented by a specific general formula and used for this color conversion composition; and a ...  
WO/2019/155400A1
The present invention relates to new maleimides having general formula (I) and their use as herbicides.  
WO/2019/153324A1
The present disclosure relates to derivatives of 7-fatty acid substituted benzoxaborole and their preparation and use. The structural general formula of the derivatives is (I). The derivatives are used for the preparation of a medicament...  
WO/2019/153080A1
The present application relates to compounds of Formula I (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodru...  
WO/2019/151121A1
A compound represented by general formula (1). (In general formula (1), Ar1 and Ar2 may be the same or different, and are either a 5-membered aromatic ring, a 6-membered aromatic ring, or a fused aromatic ring in which two or more five-m...  
WO/2019/151133A1
Bortezomib has various crystal forms. Active pharmaceutical ingredients for pharmaceuticals must be in a single crystal form in order to ensure uniform quality and physical properties such as solubility. However, bortezomib type-II cryst...  
WO/2019/146332A1
A pyrromethene boron complex according to one embodiment of the present invention is a compound which is represented by general formula (1), and which satisfies at least one of conditions (A) and (B). This pyrromethene boron complex is u...  
WO/2019/146678A1
A polarizing film including polyvinyl alcohol (A), at least one species of boron-containing compound (B) selected from the group consisting of diboronic acids represented by formula (I) and compounds that can be transformed to such a dib...  
WO/2019/146869A1
Provided is a novel compound useful as a hole transport material for an organic electronic device, in particular, an organic electroluminescent (EL) device. The compound of the present specification is represented by the following Genera...  
WO/2019/142854A1
The present invention establishes a technique enabling easy synthesis of a boronic acid ester compound at low cost with high efficiency through a small number of steps without the need of a complicated chemical technique or reagents that...  
WO/2019/143718A1
Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions,...  
WO/2019/138422A1
The present invention provides a novel and improved process for the preparation of Crisaborole of Formula (I) and its pharmaceutically acceptable salts. The present invention also provides novel intermediates and process for the preparat...  
WO/2019/134556A1
A small-molecule compound capable of inhibiting phosphodiesterase 4 (PDE-4 enzyme), a preparation method thereof, and a pharmaceutical composition comprising the compound. The compound is a boron-containing small molecule having a quinol...  
WO/2018/086730A9
Metal complexes including cyclopentadienyl ligands and methods of using such metal complexes to prepare metal-containing films are provided.  
WO/2019/131691A1
Provided is a fused-ring compound which exhibits an excellent charge-transporting ability over a long period and is useful in producing organic electroluminescent elements. The fused-ring compound has a specific structure and is represen...  
WO/2019/128633A1
The present invention relates to a boron-containing heterocyclic compound, a high polymer, a mixture, and a composition and the use thereof, wherein the boron-containing heterocyclic compound has a structure as shown in general formula (...  
WO/2019/132040A1
Provided is a compound represented by equation (1) below (where, at least one among R1-R8 is a group represented by equation (2) below).  
WO/2019/132506A1
The present specification provides a compound of chemical formula 1 and an organic light emitting element comprising the same.  
WO/2019/133699A1
The present disclosure relates to a capped dual-headed organoaluminum composition having the formula (I) and processes to prepare the same. In at least one aspect, the capped dual-headed organoaluminum compositions can be used in olefin ...  
WO/2019/131898A1
The present invention realizes a technology that makes it possible to efficiently and inexpensively synthesize an organic magnesium compound simply, in a small number of steps, and without requiring cumbersome chemistry procedures. The p...  
WO/2019/133705A1
The present disclosure relates to dual-headed organoaluminum compositions having the formula (I) and processes to prepare the same. In at least one aspect, the compositions having the formula (I) may be used during olefin polymerization.  
WO/2019/131079A1
By using this novel compound which is represented by general formula (1) and which includes boron as a spiro atom, and a macromolecular compound of said compound, the present invention provides a superior organic EL element. (1): Rings A...  
WO/2019/132479A1
The present specification relates to a nitrogen-containing cyclic compound, and a color conversion film, a backlight unit and a display device including the same.  
WO/2019/132028A1
This compound is represented by formula (1) (one or more of pairs among R12 and R13, R13 and R14, R14 and R15, R16 and R17, R17 and R18, and R18 and R19 each independently form a ring represented by formula (2A) or a ring represented by ...  
WO/2019/130229A1
The present invention relates to a process for preparing rucaparib or pharmaceutically acceptable salts thereof. It also provides novel intermediates that may be converted into rucaparib or pharmaceutically acceptable salts thereof.  

Matches 1 - 50 out of 9,518